Get the Stockscreener App
1.63
5.78%
-0.10
After Hours:
1.58
-0.05
-3.07%
Biorestorative Therapies Inc stock is traded at $1.63, with a volume of 59,689.
It is down -5.78% in the last 24 hours and up +10.14% over the past month.
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.
See More
Previous Close:
$1.73
Open:
$1.7
24h Volume:
59,689
Relative Volume:
0.42
Market Cap:
$13.00M
Revenue:
$149.50K
Net Income/Loss:
$-6.96M
P/E Ratio:
-1.1985
EPS:
-1.36
Net Cash Flow:
$-6.37M
1W Performance:
-10.88%
1M Performance:
+10.14%
6M Performance:
+13.99%
1Y Performance:
+0.00%
1-Day Range:
$1.56
$1.70
1-Week Range:
$1.56
$1.89
52-Week Range:
$1.21
$2.55
Biorestorative Therapies Inc Stock (BRTX) Company Profile
Name
Biorestorative Therapies Inc
Sector
Industry
Phone
(631) 760-8100
Address
40 MARCUS DRIVE, MELVILLE
Compare BRTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BRTX
Biorestorative Therapies Inc
|
1.63 | 13.80M | 149.50K | -6.96M | -6.37M | -1.36 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Biorestorative Therapies Inc Stock (BRTX) Latest News
Does BioRestorative Therapies Inc. have a sustainable dividendJuly 2025 Rallies & Free Accurate Trade Setup Notifications - khodrobank.com
Risk adjusted return profile for BioRestorative Therapies Inc. analyzedWeekly Stock Report & Low Volatility Stock Recommendations - Newser
Tick level data insight on BioRestorative Therapies Inc. volatilityJuly 2025 Action & AI Enhanced Trading Signals - Newser
Exit strategy if you’re trapped in BioRestorative Therapies Inc.Portfolio Update Summary & Real-Time Chart Pattern Alerts - Newser
Visual analytics tools that track BioRestorative Therapies Inc. performanceJuly 2025 Fed Impact & Accurate Buy Signal Notifications - Newser
How moving averages guide BioRestorative Therapies Inc. tradingTrade Signal Summary & Intraday High Probability Alerts - Newser
BioRestorative Therapies Inc. stock retracement – recovery analysisGap Up & High Accuracy Investment Signals - Newser
Stock Recap: Does BioRestorative Therapies Inc. have a sustainable dividendTrade Entry Report & Weekly Watchlist for Consistent Profits - khodrobank.com
Ranking BioRestorative Therapies Inc. among high performing stocks via toolsWeekly Profit Report & Smart Money Movement Tracker - Newser
Will BioRestorative Therapies Inc. stock go up in YEARMarket Risk Report & AI Forecast for Swing Trade Picks - khodrobank.com
Is BioRestorative Therapies Inc. stock a good dividend stockJuly 2025 WrapUp & Free Low Drawdown Momentum Trade Ideas - khodrobank.com
Comparing BioRestorative Therapies Inc. in custom built stock radarsJuly 2025 Update & Daily Chart Pattern Signals - Newser
Will BioRestorative Therapies Inc. benefit from macro trendsPortfolio Update Summary & Daily Stock Momentum Reports - Newser
Using AI based signals to follow BioRestorative Therapies Inc.Earnings Performance Report & Growth Focused Stock Reports - Newser
Building trade automation scripts for BioRestorative Therapies Inc.July 2025 Price Swings & Free Expert Approved Momentum Trade Ideas - Newser
Recovery Signals Appearing in BioRestorative Therapies Inc. Charts getLinesFromResByArray error: size == 0 - thegnnews.com
Can BioRestorative Therapies Inc. expand into new marketsMarket Rally & Daily Entry Point Alerts - khodrobank.com
Is BioRestorative Therapies Inc. stock heavily shortedPortfolio Value Summary & Short-Term Trading Alerts - khodrobank.com
Is BioRestorative Therapies Inc. in a consolidation phasePortfolio Value Summary & Reliable Intraday Trade Alerts - khodrobank.com
Automated trading signals detected on BioRestorative Therapies Inc.Trade Analysis Report & Consistent Profit Focused Trading Strategies - Newser
Rate Cut: What’s the beta of BioRestorative Therapies Inc. stockMarket Movers & Risk Managed Investment Entry Signals - khodrobank.com
Is BioRestorative Therapies Inc. showing signs of accumulationGold Moves & Free Safe Capital Growth Stock Tips - Newser
Published on: 2025-08-31 08:33:16 - Newser
Predicting BioRestorative Therapies Inc. trend using moving averagesWeekly Loss Report & Weekly Hot Stock Watchlists - Newser
How BioRestorative Therapies Inc. stock performs during market volatility getLinesFromResByArray error: size == 0 - sisain.net
Key resistance and support levels for BioRestorative Therapies Inc.Portfolio Risk Report & Weekly High Potential Stock Alerts - Newser
Forecasting BioRestorative Therapies Inc. price range with options dataBull Run & Target Return Focused Stock Picks - Newser
Published on: 2025-08-30 11:53:11 - Newser
Visualizing BioRestorative Therapies Inc. stock with heatmapsBear Alert & Low Risk High Win Rate Stock Picks - Newser
How high can BioRestorative Therapies Inc. stock goQuarterly Profit Report & Real-Time Volume Analysis - Newser
Using Ichimoku Cloud for BioRestorative Therapies Inc. technicalsProduct Launch & Stepwise Trade Signal Implementation - Newser
Biorestorative Therapies Inc Stock (BRTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.75%
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):